Eversio Wellness Announces Inclusion on Health Canada's List of Licensed Psilocybin Producers – Yahoo Finance

Share Article

Check back at 8:30 a.m. ET for results
SURREY, BC / ACCESSWIRE / January 31, 2022 / Eversio Wellness Ltd. ("Eversio" or the "Company"), a Canadian mushroom wellness company, is pleased to announce that it has been included on Health Canada's list of federally licenced psilocybin producers.
Health Canada's list of approved psilocybin producers provides qualified healthcare practitioners access to psilocybin as an alternative treatment for patients under its Special Access Program (SAP), and researchers with a source of natural psilocybin for the purpose of conducting clinical trials in Canada. The SAP is a federal program that allows qualified healthcare practitioners to request for their patients, specific non-marketed medications that demonstrate clinical evidence of safety and efficacy.
This list is available upon request to qualified healthcare practitioners interested in accessing psilocybin through the SAP or for scientific research.
On January 5, 2022, Health Canada enacted formal amendments to the SAP with the intent to increase access to psychedelics-based therapies that were previously available only through clinical trials.
"Eversio means change, and this is the change we've been patiently waiting for. As a company with a Controlled Substance Dealer's Licence and a mission to change lives through fungi, this amendment brings us one step closer to providing those with physical, emotional, and mental health issues access to legal natural psilocybin through consultation with their physician," said Craig Garden, Chief Executive Officer of Eversio Wellness. "We are honoured to be the first supplier shown on Health Canada's list."
Psilocybin producing mushrooms, commonly known as magic mushrooms, contain the naturally occurring psychoactive compound, psilocybin, and have been involved in numerous clinical trials and studies investigating their potential benefits for treating depression, post-traumatic stress disorder, addiction and withdrawal, autoimmune diseases and other brain health conditions.
For more information about the SAP and Eversio Wellness, please email hello@eversiowellness.com.
ABOUT EVERSIO WELLNESS LTD.
Eversio is a Canadian mushroom wellness company providing high-potency, organic functional mushroom extract products and developing novel formulations with psilocybin. Eversio offers functional mushroom extract capsules and blends made from only the whole fruiting body of the functional mushroom life cycle with a therapeutic dose of beneficial compounds in each serving. No mycelium, fillers, or grain. For more information on Eversio, visit: https://www.eversiowellness.com/.
CONTACT:
Craig Garden, Co-Founder and CEO, Eversio Wellness Ltd.
craigg@eversiowellness.com
778.608.4200
FORWARD-LOOKING INFORMATION
This news release contains forward-looking information within the meaning of Canadian securities laws regarding the Company and its business, which relate to future events or future performance and reflect management's current expectations and assumptions. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, without limitation, risks regarding the Company's ability to bring its products to commercial production, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company's products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation.
SOURCE: Eversio Wellness Ltd.

View source version on accesswire.com:
https://www.accesswire.com/686490/Eversio-Wellness-Announces-Inclusion-on-Health-Canadas-List-of-Licensed-Psilocybin-Producers

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorization (CMA) for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older in Great Britain. The vaccine, also known
After a terrific Tuesday, shares of marijuana stocks are getting stubbed out on Wednesday. As of 1:30 p.m. ET, Tilray (NASDAQ: TLRY) shares are down 2.4%, Aurora Cannabis (NASDAQ: ACB) is down 3.4%, and Canopy Growth (NASDAQ: CGC) is down 4.3%. It's all the more surprising given that, just yesterday evening, Marijuana Moment also reported that in the U.S. House of Representatives, the Secure and Fair Enforcement (SAFE) Banking Act (which is the official name of the marijuana banking law) has been refiled for consideration, and that the House Rules Committee has OK'd the bill for a vote by the full House this week.
Sorrento Therapeutics Chairman and CEO Henry Ji joins Yahoo Finance Live to discuss the Covishield antibody Sorrento is developing, the timeline for getting FDA approval, cancer treatment research, and the pharmaceutical biotech sectors.
Anavex Life Sciences on Tuesday touted the "very large" impact its treatment had on patients with Rett syndrome, but AVXL stock crashed.
The company said it will try again with the failed drug, this time as a treatment for a type of head and neck cancer.
She'd been experiencing some "abnormal pain" in her abdomen — and now, she's begging other moms to listen to their bodies.
If you need some inspiration, here are two biotech stocks that are currently down and out with investors — and while they carry some risk, I believe they have the potential to deliver strong returns to the patient shareholder: Bluebird Bio (NASDAQ: BLUE) and Exelixis (NASDAQ: EXEL). To say that Bluebird Bio has lagged the market in the past year would be an understatement. The company owes this poor showing to a combination of factors, but as is usual with biotech companies, clinical and regulatory setbacks played a significant role.
The director of the World Health Organization’s Europe office said Thursday the continent is now entering a “plausible endgame” to the pandemic and that the number of coronavirus deaths is starting to plateau. Dr. Hans Kluge said at a media briefing that there is a “singular opportunity” for countries across Europe to take control of COVID-19 transmission due to three factors: high levels of immunization due to vaccination and natural infection, the virus’s tendency to spread less in warmer weather and the lower severity of the omicron variant. As the winter subsides in much of Europe in the coming weeks, when the virus's transmission naturally drops, Kluge said the upcoming spring “leaves us with the possibility for a long period of tranquility and a much higher level of population defense against any resurgence in transmission.”
A new report conducted by the Service Employees International Union says that HCA appears to be engaging in Medicare admissions fraud by routinely admitting patients for inpatient hospital stays regardless of medical need.
What happened Shares of BioNTech (NASDAQ: BNTX) had climbed 4.3% as of 11:54 a.m. ET on Tuesday. The gain came after multiple news organizations reported that BioNTech and its big partner, Pfizer (NYSE: PFE), are expected to soon file for U.
(Reuters) -Gilead Sciences Inc on Tuesday posted lower-than-expected fourth-quarter earnings, citing a $1.25 billion legal settlement involving HIV drug patents and a charge related to its collaboration with Arcus Biosciences Inc , sending the company's shares down nearly 4%. Gilead reported adjusted quarterly earnings of 69 cents per share, down from $2.19 a year earlier. Wall Street analysts had forecast $1.60 per share, as compiled by Refinitiv.
Meditation app Calm is acquiring Ripple Health Group, a San Francisco-based healthcare technology company. Calm says the acquisition will accelerate its mental health care ambitions. Following the acquisition, Ripple Health Group CEO David Ko will take on the role of Calm co-CEO, alongside Michael Acton Smith.
When Biogen cut the price of its Alzheimer's drug in half, it exposed the arbitrary nature of drug pricing.
I spend my days getting people to open up about what they’d desperately rather keep private. Their bodies, their selves. Their health, their illness. Who they love. Their past and present. Their dreams and hopes. It’s not easy, but it should be getting easier.
As the pandemic continues, long COVID-19 remains very prevalent (affecting between 31 and 69 percent of COVID-19 patients) and somewhat bewildering because there's no clear connection between the severity of a patient's initial symptoms and how long they might linger. That was one thing that Irina Petrache, MD, chief of the division of pulmonary, critical care, and sleep medicine at National Jewish Health in Denver, noticed early on in the pandemic.
The DeFuniak Springs Police Department recently purchased four new restraint devices designed to apprehend people with little to no harm.
Canadian researchers say images of bodies like Kim Kardashian and Kylie Jenner's have a greater impact on women's body image than other body types.
Counterfeit N95 and KN95 masks are flooding the market. Here's how to tell if a respirator is real or fake, and how to buy a NIOSH-approved mask.
From nailing doing a press up properly, to smashing your personal best while running a 5k (along with tips on how), these are the best non-weight related goals.
One lot of Hard Dawn Rise and Shine, marketed as a dietary supplement for male sexual enhancement and found at Amazon.com, was recalled by EsupplementSales.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness